Skip to content

A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)

A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05612802
Enrollment
25
Registered
2022-11-10
Start date
2023-02-08
Completion date
2023-05-30
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury (Nontraumatic), Pneumoperitoneum

Brief summary

In our study, to show the effect of pneumoperitoneum on acute kidney injury in patients scheduled for laparoscopic surgery, NGAL and IGF-1 values will be measured before, after and 24 hours after pneumoperitoneum, and these values will be compared. In our study, we aimed to investigate the effect of pneumoperitoneum applied on acute kidney injury in patients who underwent laparoscopic surgery. Creatinine and NGAL have been used successfully in the follow-up of acute kidney injury. Our study investigates whether IGF-1 will be an effective indicator in acute kidney injury by comparing IGF-1 and NGAL values before pneumoperitoneum, after pneumoperitoneum and at the postoperative 24th hour.

Interventions

DIAGNOSTIC_TESTIGF-1

We need to diagnose acute kidney injury in the early postoperative period. The markers examined so far do not provide enough information to diagnose acute kidney injury early. For this reason, many different biomarkers are used in the early diagnosis of acute kidney injury in many parts of the world. Thanks to our research, we can recognise the development of acute kidney injury at an early stage and determine whether a previously unused biomarker (IGF-1) is effective in the early diagnosis of acute kidney injury.

Sponsors

Baskent University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 18-70 years of both sexes * ASA I-III Patients

Exclusion criteria

* Obesity, * Chronic Kidney Disease, * Chronic Renal Failure, * Acute Renal Failure, * Peripheral and ischemic vascular disease, * Chronic Heart Failure, * History of anaphylaxis, * A-V block, * Creatinine level \>1.4, * Neuromuscular disease, * Malignant hypertension, * Pyelonephritis, * Urinary tract infectio, * Severe inflammation/possible sepsis, * Active malignancy, * Patients with surgery reversion to laparotomy, * Hemodynamic instability, need for vasopressors, * Severe bleeding requiring blood transfusion,

Design outcomes

Primary

MeasureTime frameDescription
Diagnosis of acute kidney injury in the early postoperative period with IGF-1 (insulin like growth factor-1)before pneumoperitoneum, after pneumoperitoneum, and at the postoperative 24th hour.The researchers investigate whether IGF-1 will be an effective indicator in acute kidney injury by comparing IGF-1 and NGAL (Neutrophil gelatinase-associated lipocalin) values before pneumoperitoneum, after pneumoperitoneum and at the postoperative 24th hour.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026